Fujimoto A - Search Results

1

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome.

Fujimoto A, O'Day SJ, Taback B, Elashoff D, Hoon DS. Fujimoto A, et al. Cancer Res. 2004 Jun 15;64(12):4085-8. doi: 10.1158/0008-5472.CAN-04-0957. Cancer Res. 2004. PMID: 15205316

2

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.

Shinozaki M, Fujimoto A, Morton DL, Hoon DS. Shinozaki M, et al. Among authors: fujimoto a. Clin Cancer Res. 2004 Mar 1;10(5):1753-7. doi: 10.1158/1078-0432.ccr-1169-3. Clin Cancer Res. 2004. PMID: 15014028

3

Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.

Fujimoto A, Takeuchi H, Taback B, Hsueh EC, Elashoff D, Morton DL, Hoon DS. Fujimoto A, et al. Cancer Res. 2004 Mar 15;64(6):2245-50. doi: 10.1158/0008-5472.can-03-2932. Cancer Res. 2004. PMID: 15026369

4

Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.

Takeuchi H, Morton DL, Kuo C, Turner RR, Elashoff D, Elashoff R, Taback B, Fujimoto A, Hoon DS. Takeuchi H, et al. Among authors: fujimoto a. J Clin Oncol. 2004 Jul 1;22(13):2671-80. doi: 10.1200/JCO.2004.12.009. J Clin Oncol. 2004. PMID: 15226334 Free PMC article.

5

Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.

Takeuchi H, Fujimoto A, Hoon DS. Takeuchi H, et al. Among authors: fujimoto a. Ann N Y Acad Sci. 2004 Jun;1022:50-4. doi: 10.1196/annals.1318.009. Ann N Y Acad Sci. 2004. PMID: 15251939

6

Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma.

Umetani N, Fujimoto A, Takeuchi H, Shinozaki M, Bilchik AJ, Hoon DS. Umetani N, et al. Among authors: fujimoto a. Oncogene. 2004 Oct 28;23(50):8292-300. doi: 10.1038/sj.onc.1208022. Oncogene. 2004. PMID: 15378005

7

Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.

Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DS. Umetani N, et al. Among authors: fujimoto a. Clin Cancer Res. 2004 Nov 15;10(22):7475-83. doi: 10.1158/1078-0432.CCR-04-0689. Clin Cancer Res. 2004. PMID: 15569977

8

Assessment of genetic heterogeneity in tumors using laser capture microdissection.

Hoon DS, Fujimoto A, Shu S, Taback B. Hoon DS, et al. Among authors: fujimoto a. Methods Enzymol. 2002;356:302-9. doi: 10.1016/s0076-6879(02)56944-5. Methods Enzymol. 2002. PMID: 12418209 No abstract available.

9

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. Takeuchi H, et al. Among authors: fujimoto a. Clin Cancer Res. 2004 Apr 1;10(7):2351-8. doi: 10.1158/1078-0432.ccr-03-0195. Clin Cancer Res. 2004. PMID: 15073111

10

X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.

Takeuchi H, Kim J, Fujimoto A, Umetani N, Mori T, Bilchik A, Turner R, Tran A, Kuo C, Hoon DS. Takeuchi H, et al. Among authors: fujimoto a. Clin Cancer Res. 2005 Nov 1;11(21):7621-8. doi: 10.1158/1078-0432.CCR-05-0479. Clin Cancer Res. 2005. PMID: 16278380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

914 results

Search Page

Filters